
Loading, please wait...

Loading, please wait...

Medical device input costs in India have surged significantly due to the ongoing West Asia conflict and the near-effective blockade of the Strait of Hormuz. Consequently, the Association of Indian Medical Device Industry (AiMeD) has formally petitioned Commerce and Industry Minister Piyush Goyal for urgent intervention. They are requesting temporary customs duty rebates to maintain the affordability of essential healthcare products across the country.
The prolonged blockade of the Strait of Hormuz has disrupted a critical shipping route for the entire industry. Furthermore, these disruptions have led to unprecedented price hikes for key raw materials and energy inputs. Initially, manufacturers managed shipment delays using buffer stocks during the first few weeks. However, continued instability now threatens production slowdowns and exposes the industry to opportunistic pricing by suppliers.
Specifically, prices for critical plastics used in medical disposables have risen by 50% since the conflict began. Packaging materials also show a significant increase of over 20%. Moreover, the expanding energy crisis has led to a doubling of Adani PNG gas prices. Many facilities rely on this gas for process heating and power, making these increases particularly burdensome.
To absorb these growing expenses, the industry lobby seeks a temporary three-month customs duty rebate. Specifically, they propose a 2.5% rebate on raw material imports and a 5% rebate on components. Such measures could help domestic manufacturers offset rising costs without passing the burden to hospitals or patients. Additionally, experts emphasize the need to safeguard production timelines to prevent potential shortages of items like syringes and catheters.
Q1: Why are medical device manufacturers in India seeking duty refunds?
Manufacturers are seeking rebates to offset the sharp rise in production expenses caused by shipping disruptions and energy price hikes during the West Asia conflict.
Q2: Which materials have seen the highest price increases?
Prices for critical plastics used in disposables have surged by 50%, while packaging materials have increased by over 20% due to supply chain strain.
Q3: How has the energy crisis affected medical device manufacturing?
Curtailed commercial gas supplies have caused PNG gas prices to double, directly impacting process heating and captive power generation at manufacturing facilities.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Indian medical device industry seeks customs duty rebates to offset rising input costs and shipping delays caused by the West Asia conflict....
5 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today